Topic: How To Invest

Pat: I am looking for your opinion on Becton Dickinson. Thanks for all your advice over the years. I’ve got some cash I have been sitting on and I am ready to start buying new equities instead of just adding to my existing holdings.

Article Excerpt

Becton, Dickinson & Co., $68.21, symbol BDX on New York (Shares outstanding: 239.4 million; Market cap: $16.3 billion), is a New Jersey-based medical-supplies company that operates in three segments: BD Medical makes medical devices (such as syringes, needles and surgical supplies), and accounts for about 53% of Becton’s sales. BD Diagnostics (30% of sales) sells products that are used for collecting and transporting diagnostic specimens. It also sells instruments for microbiology and infectious-disease testing. BD Biosciences (17% of sales) makes research and clinical tools that are used in the study of cells. International sales account for about 56% of Becton’s overall revenue. In the three months ended June 30, 2009, Becton’s revenue fell 1.6%, to $1.82 billion from $1.85 billion a year earlier. If you exclude the effects of currency-exchange rates, revenue would have risen 5%. Excluding one-time items, earnings per share rose 10.2%, to $1.30 from $1.18, on fewer shares outstanding. The company’s recent cost cutting and productivity improvements offset…